Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats

Archives of Pharmacal Research

Volumn 32, Issue 5, 2009, Pages 747-753

  Cho, Cheong Weon ^a   Choi, Jun Shik ^b   Yang, Kyu Ho ^c   Shin, Sang Chul ^c  

^a Chungnam National University   (South Korea)

^b Chosun University   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

Bioavailability; Ethylene vinyl acetate matrix; Penetration enhancer; Pharmacokinetics; Pranoprofen; Transdermal administration

Indexed keywords

2 PYRROLIDONE DERIVATIVE; ACYLGLYCEROL; ETHYLENE VINYL ACETATE COPOLYMER; GLYCOL; OCTANOIC ACID; PENETRATION ENHANCING AGENT; PRANOPROFEN; SATURATED FATTY ACID; UNSATURATED FATTY ACID; BENZOPYRAN DERIVATIVE; DRUG CARRIER; ETHYLENEVINYLACETATE COPOLYMER; NONSTEROID ANTIINFLAMMATORY AGENT; OCTANOIC ACID DERIVATIVE; POLYVINYL DERIVATIVE; PROPIONIC ACID DERIVATIVE; PYRANOPROFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIFFUSION CHAMBER; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG HALF LIFE; DRUG PENETRATION; FEMORAL ARTERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; SKIN PERMEABILITY; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; BIOAVAILABILITY; BIOLOGICAL MODEL; BLOOD; CHEMISTRY; DRUG EFFECT; FEASIBILITY STUDY; INTRADERMAL DRUG ADMINISTRATION; PERMEABILITY; SKIN ABSORPTION; SPRAGUE DAWLEY RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BENZOPYRANS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; FEASIBILITY STUDIES; MALE; MODELS, BIOLOGICAL; OCTANOIC ACIDS; PERMEABILITY; POLYVINYLS; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; SKIN ABSORPTION;

EID: 67649383267     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1514-5     Document Type: Article

References (22)

1. A. Aioi K. Kuriyama T. Shimizu M. Yoshioka S. Uenoyama 1993 Effects of vitamin E and squalene on skin irritation of an absorption enhancer, laurylsarcosine Int. J. Pharm. 93 1 6
2. C. Amnuaikit I. Ikeuchi K. I. Ogawara K. Higaki T. Kimura 2005 Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use Int. J. Pharm. 289 167 178
3. R. J. Babu J. K. Pandit 2005 Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems Int. J. Pharm. 288 325 334
4. V. Carelli G. DiColo E. Nanoripieri M. Serafini 1993 Bile acids enhancers of steroid penetration through excised hairless mouse Int. J. Pharm 89 81 89
5. C. W. Cho J. S. Choi S. C. Shin 2007 Controlled release of pranoprofen from the ethylene-vinyl acetate matrix using plasticizer Drug Dev. Ind. Pharm. 33 747 753
6. Gennaro, A. R., Remington: the Science and Practice of Pharmacy 19th ed. Mack Publishing Company, Easton. PA, pp.1207-1218 (1995).
7. N. Kanikkannan K. Kandimalia S. S. Lamba M. Singh 2000 Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery Current Medicinal Chemistry 7 593 608
8. J. Levin H. Mailbach 2005 The correlation between transepidermal water loss and percutaneous absorption: an overview J. Cont. Rel. 103 291 299 (Pubitemid 40342531)
9. P. Mura M. T. Faucci G. Bramanti P. Corti 2000 Evaluation transcutol as a clonazepam transdermal permeation enhancer hydrophilic gel formulations Eur. J. Pharm. Sci. 9 365 372
10. B. N. Nalluri C. Milligan J. Chen P. A. Crooks A. L. Stinchcomb 2005 In vitro release studies on matrix type transdermal drug delivery systems. In vitro release studies on matrix type transdermal drug delivery systems of naltroxone and its acetyl prodrug Drug Dev. Ind. Pham. 31 871 887
11. T. Nomura T. Imai M. Otagiri 1993 Stereoselective disposition of pranoprofen, a nonsteroidal anti-inflammatory drug, in rabbits Biol. Pharm. Bull. 6 298 303
12. R. Panchagnula R. Bokalial P. Sharma S. Khandavilli 2005 Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies Int. J. Pharm. 293 213 223
13. M. R. Prausnitz 2004 Microneedles for transdermal drug delivery Adv. Drug Delivery News. 56 581 587
14. Roberts, M. S. and Walters, K. A. (Eds.), Dermal Absorption and Assessment, Marcel Dekker, New York, pp. 1-785 (1998).
15. K. Sagara I. Yamada Y. Matsuura M. Kawata M. Shibata 1996 Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules Biol. Pharm. Bull. 19 1184 1188
16. V. R. Shinha M. P. Kaur 2000 Permeation enhancers for transdermal drug delivery Drug Dev. Ind. Pharm. 26 1131 1140
17. S. C. Shin J. Y. Kim 2000 Enhanced permeation of triamcinolone acetonide through the buccal mucosa Eur. J. Pharm. Biopharm. 50 217 220
18. M. Y. Wang Y. Y. Yang P. W. S. Heng 2005 Skin permeation of physostigmine from acid-based formulations: evaluating the choice of solvent Int. J. Pharm. 290 25 36
19. K. S. Warner S. K. Li N. He T. M. Suhonen D. Chantasart D. Bolikal W. I. Higuchi 2003 Structure-activity relationship for chemical skin permeation enhancers; probing the chemical microenvironment of the site of action J. Pharm. Sci. 92 1305 1322
20. A. C. Williams B. W. Barry 1992 Skin absorption enhancers Crit. Rev. Ther. Drug. 9 305 353
21. A. C. Williams B. W. Barry 2004 Penetration enhancers Adv. Drug Delivery News. 56 603 618
22. K. Yamaoka Y. Tanigawara T. Nakagawa T. Uno 1981 A pharmacokinetic analysis program (multi) for microcomputer J. Pharmacobiodyn. 4 879 885